Answer
Acenocoumarol blocks vitamin K-epoxide-reductase, reducing vitamin K-dependent gamma-carboxylation of clotting factors II, VII, IX and X, a process needed for their interaction with calcium and initiation of blood clotting.
Sources for this answer
- Sinthrome Tablets 1 mgNorgine Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 6Document updated
Sources checked